Apollo Hospitals Launches First Genomics Institute in Karnataka

Bengaluru, March 29, 2025 – Apollo Hospitals has announced the launch of its first-ever Apollo Genomics Institute in Karnataka, a state-of-the-art facility dedicated to advancing genetic diagnostics and personalized medicine in India. The institute aims to integrate genomics into mainstream healthcare, enabling early diagnosis, precision treatment, and risk assessment across multiple specialties.

Led by a team of expert clinical geneticists, counselors, and researchers, the facility will focus on utilizing DNA analysis to identify genetic risks for conditions such as cancer, heart disease, and neurological disorders. By offering cutting-edge genetic testing, the institute seeks to revolutionize healthcare by providing personalized treatment plans tailored to an individual’s genetic profile.

Transforming Healthcare with Genomics

With India facing a rising burden of genetic disorders, hereditary cancers, and lifestyle diseases, the Apollo Genomics Institute aims to bridge the gap in early disease detection and risk prediction. The institute will have a significant impact in key medical specialties, including:

Oncology – Hereditary cancer screening and risk assessment

Obstetrics & Gynecology – Prenatal testing and pregnancy loss management

Pediatrics & Neonatology – Diagnosis of congenital and metabolic disorders

Neurology & Nephrology – Genetic evaluation of neurological and kidney diseases


Advanced Genetic Diagnostics & Research

In collaboration with Apollo Diagnostics, the institute will offer advanced genetic tests such as Next-Generation Sequencing (NGS), multi-gene panel testing, tumor genomic profiling, and prenatal genetic screening (NIPT, PGT-A, PGT-M). Additionally, it will foster research collaborations through the Pan-Apollo Genomic Network, connecting experts across India to further the field of genomics.

“With the Apollo Genomics Institute, we are revolutionizing healthcare by making advanced genetic diagnostics accessible to Indian patients,” said Dr. Manish Mattoo, CEO of Apollo Hospitals, Karnataka and Central Region.

The launch of the Apollo Genomics Institute marks a significant milestone in India’s healthcare landscape, positioning Karnataka as a key hub for cutting-edge genomic research and diagnostics.

City Today News 9341997936

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.